Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Genome Biology|December 22, 2017
Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer developmentYuting Chen, Martin Widschwendter, Andrew E Teschendorff
BMC Bioinformatics|April 23, 2016
Stochastic epigenetic outliers can define field defects in cancerAndrew E Teschendorff, Allison Jones, Martin Widschwendter
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Distinctive topology of age-associated epigenetic drift in the human interactomeJames West, Martin Widschwendter, Andrew E Teschendorff
Epigenomics|April 23, 2016
Epigenetic drift, epigenetic clocks and cancer riskShijie C Zheng, Martin Widschwendter, Andrew E Teschendorff
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2012
Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstructionNyaladzi Balogun, Alastair Forbes, Martin Widschwendter, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 2, 2011
Underlying mechanisms of ovarian cancer risk reduction after tubal ligationDavid Cibula, Martin Widschwendter, Michael Zikan, et al.
BMJ Open|December 13, 2012
A randomised controlled trial comparing surgical intervention rates between two protocols for the management of asymptomatic adnexal tumours in postmenopausal womenNatalie Nunes, Xulin Foo, Martin Widschwendter, et al.
Plos One|June 13, 2019
Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countriesFelix G Rebitschek, Nora Pashayan, Martin Widschwendter, et al.
Genome Biology|July 15, 2015
An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancerZhen Yang, Allison Jones, Martin Widschwendter, et al.
Briefings in Bioinformatics|June 19, 2018
Accounting for differential variability in detecting differentially methylated regionsYa Wang, Andrew E Teschendorff, Martin Widschwendter, et al.
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Genome Biology|December 22, 2017
Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer developmentYuting Chen, Martin Widschwendter, Andrew E Teschendorff
BMC Bioinformatics|April 23, 2016
Stochastic epigenetic outliers can define field defects in cancerAndrew E Teschendorff, Allison Jones, Martin Widschwendter
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Distinctive topology of age-associated epigenetic drift in the human interactomeJames West, Martin Widschwendter, Andrew E Teschendorff
Epigenomics|April 23, 2016
Epigenetic drift, epigenetic clocks and cancer riskShijie C Zheng, Martin Widschwendter, Andrew E Teschendorff
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2012
Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstructionNyaladzi Balogun, Alastair Forbes, Martin Widschwendter, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 2, 2011
Underlying mechanisms of ovarian cancer risk reduction after tubal ligationDavid Cibula, Martin Widschwendter, Michael Zikan, et al.
BMJ Open|December 13, 2012
A randomised controlled trial comparing surgical intervention rates between two protocols for the management of asymptomatic adnexal tumours in postmenopausal womenNatalie Nunes, Xulin Foo, Martin Widschwendter, et al.
Plos One|June 13, 2019
Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countriesFelix G Rebitschek, Nora Pashayan, Martin Widschwendter, et al.
Genome Biology|July 15, 2015
An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancerZhen Yang, Allison Jones, Martin Widschwendter, et al.
Briefings in Bioinformatics|June 19, 2018
Accounting for differential variability in detecting differentially methylated regionsYa Wang, Andrew E Teschendorff, Martin Widschwendter, et al.
Pageof 18